106 related articles for article (PubMed ID: 20051521)
1. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
Ramagopalan SV; Sadovnick AD; Ebers GC; Giovannoni G
Mult Scler; 2010 Jan; 16(1):127-8. PubMed ID: 20051521
[No Abstract] [Full Text] [Related]
2. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H
Mult Scler; 2009 Apr; 15(4):431-6. PubMed ID: 19153174
[TBL] [Abstract][Full Text] [Related]
3. Infectious mononucleosis-linked HLA class I single nucleotide polymorphism is associated with multiple sclerosis.
Jafari N; Broer L; Hoppenbrouwers IA; van Duijn CM; Hintzen RQ
Mult Scler; 2010 Nov; 16(11):1303-7. PubMed ID: 20736246
[TBL] [Abstract][Full Text] [Related]
4. Role of the HLA system in the association between multiple sclerosis and infectious mononucleosis.
Ramagopalan SV; Meier UC; Conacher M; Ebers GC; Giovannoni G; Crawford DH; McAulay KA
Arch Neurol; 2011 Apr; 68(4):469-72. PubMed ID: 21482926
[TBL] [Abstract][Full Text] [Related]
5. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
Ligers A; Dyment DA; Willer CJ; Sadovnick AD; Ebers G; Risch N; Hillert J;
Am J Hum Genet; 2001 Oct; 69(4):900-3. PubMed ID: 11519010
[TBL] [Abstract][Full Text] [Related]
6. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS.
Yaouanq J; Semana G; Eichenbaum S; Quelvennec E; Roth MP; Clanet M; Edan G; Clerget-Darpoux F
Science; 1997 May; 276(5313):664-5. PubMed ID: 9157540
[No Abstract] [Full Text] [Related]
7. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
[TBL] [Abstract][Full Text] [Related]
8. Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
Disanto G; Hall C; Lucas R; Ponsonby AL; Berlanga-Taylor AJ; Giovannoni G; Ramagopalan SV;
Mult Scler; 2013 Sep; 19(10):1355-8. PubMed ID: 23413297
[TBL] [Abstract][Full Text] [Related]
9. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.
Laaksonen M; Pastinen T; Sjöroos M; Kuokkanen S; Ruutiainen J; Sumelahti ML; Reijonen H; Salonen R; Wikström J; Panelius M; Partanen J; Tienari PJ; Ilonen J
J Neuroimmunol; 2002 Jan; 122(1-2):140-5. PubMed ID: 11777553
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients.
Ban M; Sawcer SJ; Heard RN; Bennetts BH; Adams S; Booth D; Perich V; Setakis E; Compston A; Stewart GJ
J Neuroimmunol; 2003 Oct; 143(1-2):60-4. PubMed ID: 14575915
[TBL] [Abstract][Full Text] [Related]
13. [Genetic risk factors for multiple sclerosis in the population of Altay].
Smagina IV; El'chaninova SA; Zolovkina AG; Ignatova IuN; Kudriavtseva EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):42-5. PubMed ID: 21666592
[TBL] [Abstract][Full Text] [Related]
14. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
[TBL] [Abstract][Full Text] [Related]
15. Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India.
Kankonkar S; Jeyanti G; Singhal BS; Shankarkumar U
Hum Immunol; 2003 Apr; 64(4):478-82. PubMed ID: 12651075
[TBL] [Abstract][Full Text] [Related]
16. Ireland: a fine place for multiple sclerosis research.
Taylor BV
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):237. PubMed ID: 21325022
[No Abstract] [Full Text] [Related]
17. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714
[TBL] [Abstract][Full Text] [Related]
18. A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele.
Goris A; Walton A; Ban M; Dubois B; Compston A; Sawcer S
Tissue Antigens; 2008 Oct; 72(4):401-3. PubMed ID: 18647361
[TBL] [Abstract][Full Text] [Related]
19. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
20. Genetics of multiple sclerosis.
Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 1997; 6(10):1693-8. PubMed ID: 9300661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
